Wirostko Barbara 4/A
4/A · EYEGATE PHARMACEUTICALS INC · Filed Jun 13, 2018
Insider Transaction Report
Form 4/AAmended
Wirostko Barbara
Chief Medical Officer
Transactions
- Award
Common Stock
2018-06-07$0.52/sh+9,600$4,992→ 249,997 total - Award
Common Stock
2018-06-08$0.54/sh+7,000$3,780→ 59,915 total(indirect: By Spouse) - Award
Common Stock
2018-06-07$0.52/sh+2,215$1,152→ 52,915 total(indirect: By Spouse)
Footnotes (1)
- [F1]The Form 4 previously filed on June 11, 2018 inadvertently misclassified the 2,215 shares purchased on June 7, 2018 and 7,000 shares purchased on June 8, 2018 as being beneficially owned directly by the reporting person instead of indirectly, and inadvertently omitted the purchase of 9,600 shares by the reporting person on June 7, 2018, which are beneficially owned directly. This amendment corrects that error to add the omitted transaction from June 7, 2018 and to reflect the correct number of shares beneficially owned by the reporting person, both directly and indirectly, after the reported transaction.